Form 8-K - Current report:
SEC Accession No. 0001213900-25-002106
Filing Date
2025-01-08
Accepted
2025-01-08 16:38:20
Documents
34
Period of Report
2025-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0227224-8k_adial.htm   iXBRL 8-K 26053
2 CORPORATE PRESENTATION OF ADIAL PHARMACEUTICALS, INC., DATED JANUARY 2025 ea022722401ex99-1_adial.htm EX-99.1 35837
3 GRAPHIC ex99-1_001.jpg GRAPHIC 325282
4 GRAPHIC ex99-1_002.jpg GRAPHIC 382363
5 GRAPHIC ex99-1_003.jpg GRAPHIC 140078
6 GRAPHIC ex99-1_004.jpg GRAPHIC 332152
7 GRAPHIC ex99-1_005.jpg GRAPHIC 321327
8 GRAPHIC ex99-1_006.jpg GRAPHIC 299547
9 GRAPHIC ex99-1_007.jpg GRAPHIC 271428
10 GRAPHIC ex99-1_008.jpg GRAPHIC 337914
11 GRAPHIC ex99-1_009.jpg GRAPHIC 284191
12 GRAPHIC ex99-1_010.jpg GRAPHIC 192777
13 GRAPHIC ex99-1_011.jpg GRAPHIC 214614
14 GRAPHIC ex99-1_012.jpg GRAPHIC 253160
15 GRAPHIC ex99-1_013.jpg GRAPHIC 290333
16 GRAPHIC ex99-1_014.jpg GRAPHIC 299705
17 GRAPHIC ex99-1_015.jpg GRAPHIC 319980
18 GRAPHIC ex99-1_016.jpg GRAPHIC 279369
19 GRAPHIC ex99-1_017.jpg GRAPHIC 216209
20 GRAPHIC ex99-1_018.jpg GRAPHIC 250721
21 GRAPHIC ex99-1_019.jpg GRAPHIC 227929
22 GRAPHIC ex99-1_020.jpg GRAPHIC 163913
  Complete submission text file 0001213900-25-002106.txt   7690331

Data Files

Seq Description Document Type Size
23 XBRL SCHEMA FILE adil-20250108.xsd EX-101.SCH 3006
24 XBRL LABEL FILE adil-20250108_lab.xml EX-101.LAB 34240
25 XBRL PRESENTATION FILE adil-20250108_pre.xml EX-101.PRE 22353
36 EXTRACTED XBRL INSTANCE DOCUMENT ea0227224-8k_adial_htm.xml XML 3657
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

EIN.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 25519007
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)